Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 8;13(1):2249.
doi: 10.1038/s41598-023-28864-x.

Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients

Affiliations

Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients

Eman M Khedr et al. Sci Rep. .

Abstract

The earlier the diagnosis of multiple sclerosis (MS), the sooner disease-modifying treatments can be initiated. However, significant delays still occur in developing countries. We aimed to identify factors leading to delayed diagnosis of MS in Upper Egypt. One hundred forty-two patients with remitting relapsing MS (RRMS) were recruited from 3 MS units in Upper Egypt. Detailed demographic and clinical data were collected. Neurological examination and assessment of the Disability Status Scale (EDSS) were performed. The mean age was 33.52 ± 8.96 years with 72.5% of patients were females. The mean time from symptom onset to diagnosis was 18.63 ± 27.87 months and the median was 3 months. Seventy-two patients (50.7%) achieved diagnosis within three months after the first presenting symptom (early diagnosis), while seventy patients (49.3%) had more than three months delay in diagnosis (delayed diagnosis). Patients with a delayed diagnosis frequently presented in the period before 2019 and had a significantly higher rate of initial non-motor presentation, initial non-neurological consultations, prior misdiagnoses, and a higher relapse rate. Another possible factor was delayed MRI acquisition following the initial presentation in sixty-six (46.5%) patients. Multivariable logistic regression analysis demonstrated that earlier presentation, initial non-neurological consultation, and prior misdiagnosis were independent predictors of diagnostic delay. Despite advances in MS management in Egypt, initial non-neurological consultation and previous misdiagnoses are significant factors responsible for delayed diagnosis in Upper Egypt.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flowchart of patient selection.

Similar articles

Cited by

References

    1. Stenager E. A global perspective on the burden of multiple sclerosis. Lancet Neurol. 2019;18(3):227–228. doi: 10.1016/S1474-4422(18)30498-8. - DOI - PubMed
    1. Stahnke AM, Holt KM. Ocrelizumab: A new B-cell therapy for relapsing remitting and primary progressive multiple sclerosis. Ann. Pharmacother. 2018;52(5):473–483. doi: 10.1177/1060028017747635. - DOI - PubMed
    1. Derfuss T, Mehling M, Papadopoulou A, Bar-Or A, Cohen JA, Kappos L. Advances in oral immunomodulating therapies in relapsing multiple sclerosis. Lancet Neurol. 2020;19(4):336–347. doi: 10.1016/S1474-4422(19)30391-6. - DOI - PubMed
    1. Moradi N, Sharmin S, Malpas C, Ozakbas S, Shaygannejad V, Terzi M, et al. Utilization of multiple sclerosis therapies in the middle east over a decade: 2009–2018. CNS Drugs. 2021;35(10):1097–1106. doi: 10.1007/s40263-021-00833-w. - DOI - PubMed
    1. Damal K, Stoker E, Foley JF. Optimizing therapeutics in the management of patients with multiple sclerosis: A review of drug efficacy, dosing, and mechanisms of action. Biologics Targets Ther. 2013;2013(7):247–258. doi: 10.2147/BTT.S53007. - DOI - PMC - PubMed

Publication types